MAP4 and nonpapillary renal cell carcinoma: Overall, the present study found a vital signaling axis CHKB-AS1-MAP4-PI3K/Akt/mTOR and it enormously contributed to the formation of resistance to NVP-BEZ235 in ccRCC, badly impairing the antitumor efficacy of NVP-BEZ235.